CURRUS BIOLOGICS
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
CURRUS BIOLOGICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.currusbio.com
Total Employee:
1+
Status:
Active
Contact:
+61 9657 0777
Email Addresses:
[email protected]
Total Funding:
10 M AUD
Technology used in webpage:
Euro Microsoft Exchange Online
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series A - Currus Biologics
Uniseed Ventures
Uniseed Ventures investment in Series A - Currus Biologics
Official Site Inspections
http://www.currusbio.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Currus Biologics"
Currus Biologics Pty Ltd
CAR-T cell therapy works by extracting a patient’s T-cells and genetically engineering these cells to produce chimeric antigen receptors (CARs) that can be used to specifically seek out and destroy cancer cells after infusion back into …See details»
Currus Biologics - Crunchbase Company Profile & Funding
Organization. Currus Biologics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
Scientific Team - Currus Team — Currus Biologics Pty Ltd
Dr Julian Clark is a Non-Executive Director of Currus Biologics. Drawing on many years of international experience Julian has played a key role in the translation of medical and health …See details»
Currus Biologics - Overview, News & Similar companies - ZoomInfo
Currus Biologics contact info: Phone number: +82 645510194 Website: www.currusbio.com What does Currus Biologics do? Currus Biologics Pty Ltd is a company that operates in the …See details»
Currus Biologics - Company Profile - Tracxn
Nov 30, 2024 Email ID: *****@currusbio.com; Phone Number: +61 ***** Key Metrics. Total Funding. $10M in 1 round. Latest Funding Round. Series A, Jun 28, 2021, $10M. Investors. …See details»
CURRUS BIOLOGICS PTY LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CURRUS BIOLOGICS PTY LTD. of Melbourne, VICTORIA. Get the latest business insights from Dun & …See details»
Currus Biologics Pty Ltd | LinkedIn
A day in the life of Currus Biologics Pty Ltd inventor, scientific advisor and Peter MacCallum Cancer Centre Senior Research fellow Clare Slaney was recently profiled in The Age.Clare shares her ...See details»
Team - Currus Biologics Pty Ltd
Dr Michael Bettess Chair. Michael is an Investment Manager at life science specialist venture capital firm Brandon Capital Partners (BCP). He is also an Executive Director at BCP investee …See details»
Currus Biologics - PitchBook
Currus Biologics General Information Description. Developer of CAR-T cell therapies designed to treat solid cancers. The company specializes in bispecific antigen-presenting and T-cell engagers for the treatment of breast, colon, …See details»
Currus Biologics - Products, Competitors, Financials, Employees ...
Currusbio.com. Overview & Products; Financials; People; Stage Series A | Alive. Total Raised $7.5M. Last Raised $7.5M | 3 yrs ago. Mosaic Score. The Mosaic Score is an algorithm that …See details»
Currus Biologics - VentureRadar
Similar Companies: Pan Cancer T Netherlands Privately Held Pan Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and …See details»
Currus Biologics - Uniseed
Website: www.currusbio.com Currus Biologics is a start-up company from the Peter Macallum Cancer Institute, Melbourne that is developing a platform technology to improve the efficacy of …See details»
Currus Biologics - Brandon Capital
San Francisco. Brandon Capital LLC. 1 Letterman Ave, Suite C3-330. San Francisco, CA 94129. Phone +61 3 9657 0700. Email: [email protected]See details»
Currus Biologics builds out clinical advisory team -Melbourne ...
Currus Biologics, a biotechnology company focused on improving lives by developing CAR T-cell therapy for solid tumour indications using its BEAT technology has further expanded its clinical …See details»
Currus Biologics – Brandon BioCatalyst
Currus Biologics is utilising its proprietary BEAT technology to develop CAR-T cell therapies that treat solid tumour cancers traditionally difficult to treat with current CAR-T cell therapies.See details»
Contact - Currus Biologics Pty Ltd
Email: [email protected] ABN 82 645 510 194 WE DO NOT CURRENTLY HAVE ANY JOBS ADVERTISED NOR DO WE HAVE ANY POSITIONS AVAILABLE. THE TEAM LISTED ON …See details»
Currus Biologics – Brandon BioCatalyst
Currus Biologics is developing its proprietary BEAT technology for solid tumors, to enable the use of CAR-T cell therapies for the treatment of solid tumor indications.See details»
Currus Biologics launches with AU$10M series A to tackle CAR
Jun 29, 2021 PERTH, Australia – Startup Currus Biologics Pty Ltd. has launched with a AU$10 million (US$7.5 million) series A round with the mission of improving the success of CAR T-cell …See details»
News & Publications - Currus Biologics Pty Ltd
June 2021: $10m invested into start-up developing new treatments targeting the use of CAR-T cell therapies against solid tumours . Currus Biologics raises $10 million Series A investment …See details»
The Technology - Currus Biologics Pty Ltd
In several models of solid tumours, the combination of the BEAT concept and CAR-T cell therapy has demonstrated strong CAR-T cell proliferation and persistence with CAR-T cell trafficking …See details»